Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (1y) (2010 - 2026)
Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 88.70% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.72% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 3.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98% |
| Dec 31, 2025 | -13.28% |
| Sep 30, 2025 | 29.48% |
| Jun 30, 2025 | 255.31% |
| Mar 31, 2025 | -40.82% |
| Dec 31, 2024 | 26.83% |
| Sep 30, 2024 | 22.70% |
| Jun 30, 2024 | -70.11% |
| Mar 31, 2024 | 15.91% |
| Dec 31, 2023 | -46.53% |
| Sep 30, 2023 | 48.54% |
| Jun 30, 2023 | 173.90% |
| Mar 31, 2023 | -39.31% |
| Dec 31, 2022 | -29.31% |
| Sep 30, 2022 | -85.17% |
| Jun 30, 2022 | -6.15% |
| Mar 31, 2022 | 230.12% |
| Dec 31, 2021 | 107.33% |
| Sep 30, 2021 | 905.01% |
| Jun 30, 2021 | -46.20% |